The varicella-zoster virus: Systemic and ocular features (Q40077895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

review article

1 reference

title

The varicella-zoster virus: systemic and ocular features (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

The varicella-zoster virus: Systemic and ocular features (English)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

2 August 2023

1

T. J. Liesegang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090512

2 August 2023

language of work or name

English

0 references

publication date

1 August 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

https://api.elsevier.com/content/article/PII:S0190962284701484?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

https://api.elsevier.com/content/article/PII:S0190962284701484?httpAccept=text/plain

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Journal of the American Academy of Dermatology

2 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

165-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Replication of varicella-zoste virus in cell culture: an ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cell-Free Varicella-Zoster Virus in Cultured Human Melanoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

THE PATHOLOGY OF HERPES ZOSTER AND ITS BEARING ON SENSORY LOCALISATION

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Modification of chicken pox in family contacts by administration of gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cellular Events in Zoster Vesicles: Relation to Clinical Course and Immune Parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Letter: Recurrent varicella-like illness in a child with leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicelliform eruptions in herpes zoster--some clinical and serological observations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Zoster sine herpete causing acute trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

A viremic phase for herpes zoster in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Risk of Cancer after Herpes Zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Complications of herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes zoster at the NIH: A 20 year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

The natural history of herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Zoster, reinfection or activation of latent virus? Observations on the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cellular Immune Responses to Herpesviruses during Treatment with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Seroepidemiology of infectious due to members of the herpesvirus group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Should Patients With Zoster Receive Zoster Immune Globulin?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Zoster immune globulin. A further assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Complement-Enhanced Neutralizing Antibody Response to Varicella-Zoster Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Immune Adherence Hemagglutination: Further Observations on Demonstration of Antibody to Varicella-Zoster Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes Zoster in Children with Stage I–III Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Immunoregulatory T Cells in Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Rapid Method for Tzanck Preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Rapid diagnosis of varicella-zoster infections by agar-gel diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Early Diagnosis of Virus-Caused Vesicular Rashes by Lmmunofluorescence on Skin Biopsies II. Poxvirus (Vaccinia)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicella-Zoster Ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cataracts acquired following varicella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicella Vaccination: Where Do We Go From Here?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Prevention of varicella by zoster immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Therapeutic Potential of Transfer Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Transfer Factor for the Prevention of Varicella-Zoster Infection in Childhood Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Human Leukocyte Interferon for the Treatment of Varicella in Children with Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Uncertain role of cytosine arabinoside in varicella infection of compromised hosts.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Treatment of Varicella-Zoster Virus Infections with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Vidarabine therapy of varicella in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

NIH conference. Herpes zoster-varicella infections in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes zoster encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Motor lesions in herpes zoster. Incidence and special features

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes-zoster meningoencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

ZOSTER ENCEPHALOMYELITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Varicella-Zoster infection in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Evaluation of zoster immune plasma. Treatment of cutaneous disseminated zoster in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Treatment of Zoster with Idoxuridine in Dimethyl Sulphoxide. Results of Two Double-blind Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Prolonged Herpes-Zoster Infection Associated with Immunosuppressive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Failure of cytarabine in varicella-zoster infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir reaches clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir in herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir therapy for acute herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Evaluation of Topical Polyinosinic Acid-Polycytidylic Acid in Treatment of Localized Herpes Zoster in Children with Cancer: a Randomized, Double-Blind Controlled Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Triple drug therapy of Herpes zoster infection occurring in patients with reticulo-endothelial neoplasia--a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Geriatric herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Pathogenesis of varicella-zoster angiitis in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Angiographic findings in herpes zoster arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

CNS Varicella-Zoster Vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Herpes zoster dendritic keratitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

External ocular motor palsies in ophthalmic zoster: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

The acute retinal necrosis syndrome. Part 2: Histopathology and etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

The progression of the ocular abnormalities of herpes zoster. Histopathologic observations of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Histopathology of Herpes Zoster Ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Pathology of the human spinal ganglia in varicella-zoster virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Changes of the central nervous system in herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

The Effects of Early Corticosteroid Therapy on the Skin Eruption and Pain of Herpes Zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Do corticosteroids prevent post-herpetic neuralgia?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Treatment of herpes zoster and postzoster neuralgia by subcutaneous injection of triamcinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Idoxuridine in herpes zoster: further evaluation of intermittent topical therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Treatment of Herpes zoster with Idoxuridine Ointment, Including a Multivariate Analysis of Symptoms and Signs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Administration of levodopa for relief of herpes zoster pain

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Cryocautery of sensitized skin areas for the relief of pain due to post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

Amitriptyline versus placebo in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970148-4

1 reference

7 January 2021

The Histology of the Skin Lesions in Varicella

11

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

2 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Antibody Assays for Varicella-Zoster Virus: Comparison of Enzyme Immunoassay with Neutralization, Immune Adherence Hemagglutination, and Complement Fixation

2 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus

2 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

The monocyte disorder with herpes zoster

2 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes

2 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Prevention or Modification of Varicella Using Zoster Immune Plasma

2 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Varicella-zoster infections

2 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Central nervous system manifestations of chickenpox

2 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Development of a live attenuated varicella vaccine

2 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study

2 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Current management of ophthalmic herpes zoster

2 August 2023

126

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

Griseofulvin in the treatment of herpes zoster

2 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70148-4

2 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090512%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference